Research, trials, devices, and safety notices — labeled by evidence strength so you can tell solid science from hype.
Pulled from official registries and public research sources, then labeled by evidence strength before publication.
Saved on this device only. Matching items rise on Today. No health profile required.
32 items from 4 live sources. Updated Sep 3, 2026, 11:42 AM CDT.
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
RECRUITING, PHASE2. Interventions: Dulaglutide, Placebo. Locations: Orlando, Florida, United States. The investigators will test the hypothesis that, in adults with type 1 diabetes (T1D), glucagon-like peptide-1 receptor agonism (GLP-1RA, i.e. dulaglutide) enhances insulin-mediated skeletal muscle microvascular perfusion via attenuating endothelial oxidative stress and thereby improving endothelial function.
RECRUITING, PHASE2. Interventions: Tirzepatide 2.5mg weekly, Placebo injection (normal saline). Locations: Sydney, New South Wales, Australia. This study will examine the effects of Tirzepatide (TZP), a glucagon-like peptide 1 (GLP1) - gastric inhibitory peptide (GIP) co-agonist, on metabolism in type 1 diabetes (T1D). Research participants with T1D will undergo measures of insulin sensitivity, and hormone levels post-meal, post-hypoglycemia and during th...
For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This could result in missed rapid-acting insulin doses without the user s knowledge, and may lead to delayed therapy and an increased risk of hyperglycemia. Action: On 6/16/2026 In-App Push Notifications were sent to customers entitled, Important Field Safety Corrective Action required on your MiniMed Go ap...
RECRUITING. Interventions: Remote-Patient-Monitoring (RPM). Locations: Herlev, Denmark. The goal of this observational pre-post study is to evaluate a remote-patient-monitoring-system (RPM-system) integrated within an electronic health record (EHR) system in a real world cohort of approximately 12.000 people with diabetes in an outpatient care setting. The main question it aims to answer is: Whether glycemic outcomes following integration of the RPM syste...
A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and an increased risk of hyperglycemia or diabetic ketoacidosis... Action: On 5/27/2026, field safety notices were emailed to customers who were asked to do the following: 1) Update insulin pump software...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
Certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process. The sensors were later sold to pharmacies and distributors by Pharmsource, LLC. Lot 1725204004 were designated for destruction because the G7 sensors were not properly sterilized and have an increased risk of skin infection if used. Lot 1725... Action: On 05/26-27/2026, the firm issued a Press Release and sent an "URGENT: MEDICAL DEVICE CORRECTION NOTIFICATION" informing custome...
Daily briefings, device safety watches, trial roundups, and research notes — each linked back to original sources.
A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.
A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.
A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.
A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
beyondtype1.org
Promising research is happening on multiple fronts, yet people managing Type 1 diabetes today still face daily management challenges. Understanding how to hold hope and present reality together matters.
YouTube / This Month in Type 1 Diabetes Research
From transplant breakthroughs to digital tools and caregiver insights, recent research is expanding treatment options and revealing what helps young people manage their condition better.
Northeast and Western Wisconsin Chapter
Oliver Zilinskas was 10 years old when subtle symptoms—fatigue, thirst, weight loss—came together to reveal a Type 1 diabetes diagnosis. His family's story shows why recognizing these warning signs matters.
wam.ae
Researchers are making significant progress developing insulin-producing cells from stem cells that can regulate blood sugar in laboratory and animal studies. Early human trials are underway to test whether this approach can reduce or eliminate the need for insulin injections.
New Shorts daily on YouTube and TikTok
What Pregnancy Data Reveals About Blood Sugar Control and Birth Weight in Type 1 Diabetes
Your HbA1c might be lying to you during pregnancy.
What Happens When People With Type 1 Diabetes Eat Very Few Carbs? New Research Has Answers
Your low-carb diet isn't dangerous. Here's the proof.
Vitamin A and E Levels Don't Show Clear Link to Type 1 Diabetes Development
Your vitamin A and E levels might not prevent T1D.
When Cat Scratch Disease Looks Like Something Else: A Reminder for Families
Your child's fever might not be what you think.
When Type 1 Diabetes and Seizures Occur Together: Understanding a Rare Autoimmune Connection
Your T1D diagnosis might be hiding something else.
Making the Switch: A First Look at the Dexcom G7
Switching from G6 to G7? Here's what actually changes.
Why Type 1 Diabetes Is Often Missed in Adults
Your doctor might have gotten your diagnosis completely wrong.
Sleep Problems Affect More Than One-Third of Children With Type 1 Diabetes
Your T1D kid's bad sleep might not be a phase.
Updated daily from ClinicalTrials.gov
Showing 6 of 8 programs tracked
Track all 8programs →1113 evidence-labeled articles across 6 topics
Promising research is happening on multiple fronts, yet people managing Type 1 diabetes today still face daily managemen…
Read →Living With T1DResearchers are studying a stricter glucose target called time in tight range (TITR) to see if it offers benefits beyond…
Read →Eating & NutritionNew research shows that adolescents with Type 1 diabetes who have stronger nutrition knowledge tend to make healthier fo…
Read →Diagnosis & Early DetectionResearchers documented pancreatic changes visible on imaging just before a patient developed severe type 1 diabetes duri…
Read →Causes & What We KnowResearchers have developed a minimally invasive technique to identify and study the rare T cells responsible for beta ce…
Read →LifestyleNew research confirms that physically active people with uncomplicated type 1 diabetes respond to intense exercise simil…
Read →Chapter 5 — Age 17
“Closing in on seventeen, here's the short version of everything the younger me needed to hear.”
Closing in on seventeen, here's the short version of everything the younger me needed to hear.
Brooke's chapters are personal lived experience shared to make people feel less alone. They are not medical advice and do not describe a treatment plan. Talk to your own care team about your numbers, devices, and decisions.
If FDA, MedWatch, or a manufacturer issues a relevant CGM, pump, app, insulin, or glucagon alert, it should bypass the normal feed and hit the family alert lane first.
Medtronic MiniMed, Inc.
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Open alertMedtronic MiniMed, Inc.
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Open alertMedtronic MiniMed, Inc.
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Open alertMedtronic MiniMed, Inc.
For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This could result in missed rapid-acting insulin doses without the user s knowledge, and may lead to delayed therapy and an increased risk of hyperglycemia. Action: On 6/16/2026 In-App Push Notifications were sent to customers entitled, Important Field Safety Corrective Action required on your MiniMed Go ap...
Open alert